Case Report

Addisonian Crisis Precipitated by Thyroxine Therapy: A Complication of Type 2 Autoimmune Polyglandular Syndrome

Authors: Leland Graves, III, MD, Robert M. Klein, PHD, Anne D. Walling, MD

Abstract

Hypothyroidism is a common condition. Rarely, it may occur in combination with autoimmune failure of other endocrine glands (autoimmune polyendocrinopathy syndrome type 2, previously known as Schmidt's syndrome). In such cases, restoring normal thyroid function may precipitate adrenal failure. Clinicians should have a high index of suspicion for this condition in patients with Addison's disease, those with a family history of autoimmune endocrine gland failure, patients with one autoimmune endocrine disease who develop nonspecific or serious illness, and patients with type 1 diabetes mellitus whose insulin requirements drop without obvious explanation.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Schmidt MB. Eine biglanduloma Erkrankung (Nebennieren und Schilddrüse) bei Morbus Addisonii. Verh Dtsch Ges Pathol 1926; 21: 212–221.
 
2. Graber MA, Freed HA. Polyglandular autoimmune syndrome: A cause of multiple and sequential endocrine emergencies. Am J Emerg Med 1992; 10: 130–132.
 
3. Betterle C, Dal Pra C, Greggio N, et al. Autoimmunity in isolated Addison's disease and in polyglandular autoimmune diseases type 1, 2, and 4. Ann Endocrinol 2001; 62: 193–201.
 
4. Riley WJ. Autoimmune polyglandular syndromes. Horm Res 1992; 38: 9–15.
 
5. Khalil S, Evers ML. Case report: Autoimmune polyglandular syndrome. N J Med 1995; 92: 671–674.
 
6. Neufeld M, Blizzard RM. Polyglandular autoimmune diseases, in Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds): Symposium on Autoimmune Aspects of Endocrine Disorders. New York, Academic Press, 1980, pp 357–365.
 
7. Vaidya B, Pearce S, Kendall-Taylor P. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure. Clin Endocrinol 2000; 53: 403–418.
 
8. Peterson P, Uibo R, Krohn KJ. Adrenal autoimmunity: Results and developments. Trends Endocrinol Metab 2000; 11: 285–290.
 
9. Muir A, Maclaren NK. Autoimmune diseases of the adrenal glands, parathyroid glands, gonads and hypothalamic-pituitary axis. Endocrinol Metab Clin North Am 1991; 20: 619–645.
 
10. Werbel SS, Ober KP. Acute adrenal insufficiency. Endocrinol Metab Clin North Am 1993; 22: 303–328.
 
11. Davenport J, Kellerman C, Reiss D, et al. Addison's disease. Am Fam Physician 1991; 43: 1338–1342.
 
12. Zelissen PM, Bast EJ, Croughs RJ. Associated autoimmunity in Addison's disease. J Autoimmun 1995; 8: 121–130.
 
13. Chung AD, English JC. Cutaneous hyperpigmentation and polyglandular autoimmune syndrome type II. Cutis 1997; 59: 77–80.